| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 09/14/2006 | WO2006095820A1 Adhesive and adhesive patch |
| 09/14/2006 | WO2006095819A1 Sugar-coated pill |
| 09/14/2006 | WO2006095798A1 Anticancer composition for oral use comprising liposome containing phytosterols and prevention or treatment for cancer using the liposome |
| 09/14/2006 | WO2006095788A1 Particle and preparation containing the particle |
| 09/14/2006 | WO2006095668A1 Microparticle and pharmaceutical composition |
| 09/14/2006 | WO2006095095A1 Ophthalmologic compositions and use mode thereof |
| 09/14/2006 | WO2006095085A1 Novel method for obtaining a fast-dissolving imidapril powder |
| 09/14/2006 | WO2006095074A1 Anti-smoking composition |
| 09/14/2006 | WO2006094974A2 Chemically defined stabiliser composition |
| 09/14/2006 | WO2006094961A1 Transdermal therapeutic system for the administration of analgesics |
| 09/14/2006 | WO2006094829A1 Microemulsions of cannabinoid receptor binding compounds |
| 09/14/2006 | WO2006094737A2 Gastroresistant pharmaceutical formulations containing rifaximin |
| 09/14/2006 | WO2006094681A1 Non-fibrous transdermal therapeutic system and method for its production |
| 09/14/2006 | WO2006094664A1 Endoparasiticide |
| 09/14/2006 | WO2006094642A1 Emollients and cosmetic compositions based on special branched hydrocarbons |
| 09/14/2006 | WO2006094626A1 Pharmaceutical composition comprising an omega- carboxyaryl substituted diphenyl urea for the treatment of cancer |
| 09/14/2006 | WO2006094507A1 Pharmaceutical compositions comprising sirolimus and/or an analogue thereof |
| 09/14/2006 | WO2006094460A1 A medicine for treating cough and asthma and preparation method thereof |
| 09/14/2006 | WO2006078593A3 Direct compression formulation and process |
| 09/14/2006 | WO2006076097A3 Stable non-crystalline formulation comprising losartan |
| 09/14/2006 | WO2006073520A3 Dual activating tdd |
| 09/14/2006 | WO2006065888A3 Targeted iron chelator delivery system |
| 09/14/2006 | WO2006065455A9 Chewable oral compositions containing an anti-microbial agent and methods of formulating the compositions to have acceptable germ kill properties and taste |
| 09/14/2006 | WO2006064235A3 Formulations for production of capsule shells and capsules |
| 09/14/2006 | WO2006061336A3 Oral compositions for absorption of phosphorus compounds |
| 09/14/2006 | WO2006060120A3 Liposomal formulation for oral administration of glutathione (reduced) |
| 09/14/2006 | WO2006056362A3 Delivery vehicle manufactured by the miniemulsion method |
| 09/14/2006 | WO2006052742A3 Pharmaceutical analysis apparatus and method |
| 09/14/2006 | WO2006052649A3 Biodegradable cross-linked cationic multi-block copolymers for gene delivery and methods of making thereof |
| 09/14/2006 | WO2006052285A3 Polymeric nanoparticles and nanogels for extraction and release of compounds |
| 09/14/2006 | WO2006050533A3 Stabilized individually coated ramipril particles, compositions and methods |
| 09/14/2006 | WO2006050368A3 Therapeutic calcium phosphate particles iin use for aesthetic or cosmetic medicine, and methods of manufacture and use |
| 09/14/2006 | WO2006036899A3 Transdermal systems for the delivery of estrogens and progestins |
| 09/14/2006 | WO2006036007A3 Modified-release preparation |
| 09/14/2006 | WO2006029278A3 Phenolic antiseptic compositions and methods of use |
| 09/14/2006 | WO2006026592A3 Oral administration of poorly absorbed drugs, methods and compositions related thereto |
| 09/14/2006 | WO2006026174A3 Matrix composition for stable microemulsions |
| 09/14/2006 | WO2006017861A3 Treatment for methamphetamine addiction and reduction of methamphetamine use using serotonin antagonists |
| 09/14/2006 | WO2006005910A3 Pharmaceutical composition comprising botulinum, a non ionic surfactant, sodium chloride and sucrose |
| 09/14/2006 | WO2006003587A3 Solid oral dosage forms of azabicyclo derivatives |
| 09/14/2006 | WO2006002808A3 Rapidly dispersible, fine-grained, separation-resistant pulverulent film coating agent, based on polyvinyl alcohol-polyether graft copolymers and characterised by a particular physical stability and a low degree of roughness |
| 09/14/2006 | WO2005123034A3 Microparticulate systems for the oral administration of biologically active substances |
| 09/14/2006 | WO2005120462A3 Biodegradable and biocompatible crosslinked polymer hydrogel prepared from pva and/or peg macromer mixtures |
| 09/14/2006 | WO2005105120A3 Pharmaceutical combination, active on central nervous system (cns) and set of pharmaceuticals; method of treatment of cns-disorders; means facilitating penetration of the hematoencephalic barrier; pharmaceutical means for endonasal administration |
| 09/14/2006 | WO2005084710B1 Nanocell drug delivery system |
| 09/14/2006 | WO2005067583A8 Immunoliposome-nucleic acid amplication (ilnaa) assay |
| 09/14/2006 | WO2005044353A8 Powder inhaler |
| 09/14/2006 | WO2004064731A3 Lipid-drug formulations and methods for targeted delivery of lipid-drug complexes to lymlplhoid tissues |
| 09/14/2006 | US20060206099 Low profile inlet valve for a piston pump therapeutic substance delivery device |
| 09/14/2006 | US20060205951 New crystal modification of torasemide |
| 09/14/2006 | US20060205931 Pharmaceutical compositions having appetite suppressant activity |
| 09/14/2006 | US20060205863 For production of films, tubes, pipes, sheets, fibers, woven and nonwoven fabrics, automotive components, furniture, sporting equipment, food storage containers, transparent and semi-transparent articles, toys, tubing and pipes, and medical devices; improved impact resistance |
| 09/14/2006 | US20060205820 Formulations of anthraquinone derivatives |
| 09/14/2006 | US20060205806 Synergistic combination |
| 09/14/2006 | US20060205776 liquid formulation contains at least one organic acid dissolved in a solvent; chemical stability, storage stability, shelf life; treating attention-deficit disorder in children |
| 09/14/2006 | US20060205725 Method for treating ocular hypertension and glaucoma |
| 09/14/2006 | US20060205703 Stabilized steroid composition and method for its preparation |
| 09/14/2006 | US20060205661 Novel albumin-free factor VIII formulations |
| 09/14/2006 | US20060205658 Irrigation solution and method for inhibition of pain and inflammation |
| 09/14/2006 | US20060205657 Irrigation solution and method for inhibition of pain and inflammation |
| 09/14/2006 | US20060205652 Formulations and methods for delivery of growth factor analogs |
| 09/14/2006 | US20060205005 Artificial red blood cells |
| 09/14/2006 | US20060204598 Nicotine-alternative compositions and methods of producing such compositions |
| 09/14/2006 | US20060204593 Superoxide anion decomposing agent |
| 09/14/2006 | US20060204591 Treatment of mucosal membranes |
| 09/14/2006 | US20060204588 Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof |
| 09/14/2006 | US20060204587 Use of film coating as taste-masking coating of oral dosage forms |
| 09/14/2006 | US20060204586 Time release calcium sulfate matrix for bone augmentation |
| 09/14/2006 | US20060204585 Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| 09/14/2006 | US20060204584 Materials and methods relating to polyions and substance delivery |
| 09/14/2006 | US20060204583 Chemoembolisation |
| 09/14/2006 | US20060204582 Multiple phase cross-linked compositions and uses thereof |
| 09/14/2006 | US20060204581 Biomimetic organic/inorganic composites, processes for their production, and methods of use |
| 09/14/2006 | US20060204580 Biomimetic organic/inorganic composites, processes for their production, and methods of use |
| 09/14/2006 | US20060204579 administering polyethylene glycol or ethylene oxide-propylene oxide copolymers, with drugs, to improve delivery in the alimentary canal |
| 09/14/2006 | US20060204578 Dual controlled release dosage form |
| 09/14/2006 | US20060204577 Pharmaceutical Compositions of Drugs and Neutralized Acidic Polymers |
| 09/14/2006 | US20060204576 Multilayer dosage forms, which contain active substances and which comprise a neutral core, and an inner and outer coating consisting of methacrylate copolymers and methacrylate monomers |
| 09/14/2006 | US20060204575 Amphetamine formulations |
| 09/14/2006 | US20060204574 Sustained-release oral administration preparation of phenylalanine derivatives |
| 09/14/2006 | US20060204573 Control release formulation containing a hydrophobic material as the sustained release agent |
| 09/14/2006 | US20060204572 Solid dispersions or solid dispersion pharmaceutical preparations of phenylalanine derivatives |
| 09/14/2006 | US20060204571 Stable compositions of bupropion or its pharmaceutically acceptable salts |
| 09/14/2006 | US20060204570 Preparing method for controlled released type tablet tamsulosin hcl and the tablet thereof |
| 09/14/2006 | US20060204568 Oral pharmaceutical preparation for proton pump antagonists |
| 09/14/2006 | US20060204567 Potato proteinase inhibitor II exhibits activity in elevating fasting plasma cholecystokinin concentrations |
| 09/14/2006 | US20060204566 Novel liposome complexes for increased systemic delivery |
| 09/14/2006 | US20060204565 comprises a folate receptor ligand capable of binding to activated macrophages or a vitamin/vitamin-receptor binding analog and immunogen, a cytotoxin, or another compound capable of altering macrophage function |
| 09/14/2006 | US20060204564 Compositions and kits for the removal of irritating compounds from bodily surfaces |
| 09/14/2006 | US20060204563 Compositions and kits for the removal of irritating compounds from bodily surfaces |
| 09/14/2006 | US20060204559 Fast dissolving orally consumable films containing an ion exchange resin as a taste masking agent |
| 09/14/2006 | US20060204558 Antimicrobial pet wipes and methods |
| 09/14/2006 | US20060204557 Water-based personal moisturizers and lubricants, in particular vaginal lubricants, and uses thereof |
| 09/14/2006 | US20060204556 Cell-loaded prostheses for regenerative intraluminal applications |
| 09/14/2006 | US20060204555 Thermosensitive polymers for therapeutic use and methods of preparation |
| 09/14/2006 | US20060204551 Synergistic salivation agents |
| 09/14/2006 | US20060204543 Semirigid implant of glycolic acid-lactic acid copolymer with hydroxypropylmethyl cellulose as release modifier for cyclosporine; biodegradation; sustained release |
| 09/14/2006 | US20060204537 Silicone blends and composites for drug delivery |
| 09/14/2006 | US20060204532 Drug Delivery Systems and Methods for Modulating the Fetal Environment and Pregnancy Process |
| 09/14/2006 | US20060204526 Emulsive composition containing Dapsone |